跳至主要内容
临床试验/NCT03190980
NCT03190980已完成不适用

Efficacy and Safety of Oral Glucose in Pain Alleviation Among Healthy Term Neonates

Makassed General Hospital1 个研究点 分布在 1 个国家目标入组 244 人开始时间: 2017年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
244
试验地点
1
主要终点
Pain score

研究概览

简要总结

Background: It was long believed that newborns could not experience pain. As it is now documented that newborns have all the necessary systems to perceive pain, pain management can no longer be ignored.

Pharmacologic agents are not recommended in neonates for pain relief in minor procedures and still there is debate regarding the efficacy of oral glucose, in different strengths, on alleviation of pain among neonates.

Aim: The objective of this study is to assess the efficacy and safety oral administration of glucose, in different concentrations, on pain relief in full term neonates undergoing heel prick test.

Methods: The investigators will conduct a prospective, randomized, double blind placebo controlled trial to investigate the effect of glucose solution on alleviating the pain of heel prick test in 244 healthy full term newborns who will be randomly allocated to one of three groups: First group will receive 5% glucose, second group will receive 30% glucose and third group will receive sterile water as a placebo, 2 minutes prior to the procedure.

Specially trained nurses will take turns to carry out blood sampling. Neonatal pain will be assessed by the Neonatal Infant Pain (NIPS) as well as by duration of crying, changes in heart rate, respiratory rate and oxygen saturation.

详细描述

The investigators will conduct a prospective, randomized, double blind, placebo controlled study of healthy full term newborns delivered by normal vaginal delivery, undergoing heel prick test. They will be randomized to receive either 5% glucose, 30% glucose or sterile water as a placebo, 2 minutes prior to the procedure. The investigators will study the efficacy and safety of oral glucose, in different strengths, compared to placebo (sterile water) in pain alleviation.

All parents will receive an explanation of the study before participation, and informed written consent will be signed by the parents for voluntary participation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
24 Hours 至 72 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • Estimated gestational age: 37 weeks-42 weeks
  • Birth weight: 2500 grams- 4000 grams
  • Mode of delivery: normal vaginal delivery
  • Age: birth to 72 hours of life
  • Apgar scores of at least 7 at 1 and 5 minutes
  • Heart rate between 100 and 160 per minutes
  • Blood O2 saturation ≥ 95%
  • No known congenital anomalies

排除标准

  • They have history of birth trauma
  • They are admitted to neonatal intensive care unit (NICU)
  • They need respiratory support
  • Their mothers are receiving sedatives or opioids during vaginal delivery

结局指标

主要结局

Pain score

时间窗: 2 minutes during the procedure

Pain responses will be evaluated using the Neonatal Infant Pain Scale NIPS

次要结局

  • Occurance of adverse events(5 minutes after the procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amal Naous

Pediatrician

Makassed General Hospital

研究点 (1)

Loading locations...

相似试验